US Patent Issued to Massachusetts Eye and Ear Infirmary on March 25 for "Gene therapy for NMNAT1-associated retinal degeneration" (Massachusetts Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,320, issued on March 25, was assigned to Massachusetts Eye and Ear Infirmary (Boston).

"Gene therapy for NMNAT1-associated retinal degeneration" was invented by Eric A. Pierce (Belmont, Mass.), Luk H. Vandenberghe (Weston, Mass.), Scott Greenwald (Boston) and Emily Brown (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for gene therapy of retinal degeneration related to mutations in nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1)."

The patent was filed on March 11, 2021, under Application No. 17/199,115.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...